Skip to main content
Log in

A novel strategy for the preparation of the injectable PET/CT radiopharmaceutical (-)-[11C]-(1R,2S)-meta-hydroxyephedrine ((-)-[11C]HED

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Positron emission tomography (PET) had been applied in clinical early diagnosis of various tumors and other diseases. The methylated synthetic conditions of (-)-[11C]-(1R,2S)-meta-hydroxyephedrine ((-)-[11C]HED), considered as one of the most important radiopharmaceuticals for PET, were optimized through single factor and orthogonal design methods. Here, we reported an improved purification protocol. The radiochemical yields of the final product were over 45% (decay-corrected and based on [11C]methyl iodide) (n = 50). The radiochemical purities and chemical purities were over 99% (n = 50) and 97% (n = 50), respectively. The automatic radiosynthesis procedure of (-)-[11C]HED with relatively high radiochemical yield was convenient and reliable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wang B, Xie M, Li R, Owonikoko TK, Ramalingam SS, Khuri FR, Curran WJ, Wang Y, Deng X (2014) Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis. Cell Death Differ 21(7):1160–1169. https://doi.org/10.1038/cdd.2014.42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Xie MH, Wu QJ, Jiang YF, Bao P, Zhang Y (2009) A phage RNA-binding protein binds to a non-cognate structured RNA and stabilizes its core structure. Biochem Biophys Res Commun 378(2):168–173. https://doi.org/10.1016/j.bbrc.2008.10.160

    Article  CAS  PubMed  Google Scholar 

  3. Han B, Park D, Li R, Xie M, Owonikoko TK, Zhang G, Sica GL, Ding C, Zhou J, Magis AT, Chen ZG, Shin DM, Ramalingam SS, Khuri FR, Curran WJ, Deng X (2015) Small-molecule Bcl2 BH4 antagonist for lung cancer therapy. Cancer Cell 27(6):852–863. https://doi.org/10.1016/j.ccell.2015.04.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. You S, Li R, Park D, Xie M, Sica GL, Cao Y, Xiao ZQ, Deng X (2014) Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer. Mol Cancer Ther 13(3):606–616. https://doi.org/10.1158/1535-7163.MCT-13-0608

    Article  CAS  PubMed  Google Scholar 

  5. Rosenspire KC, Haka MS, Van Dort ME, Jewett DM, Gildersleeve DL, Schwaiger M, Wieland DM (1990) Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med 31(8):1328–1334

    CAS  PubMed  Google Scholar 

  6. Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, Deeb M, Wolfe E Jr, Wieland DM (1990) Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 82(2):457–464

    Article  CAS  PubMed  Google Scholar 

  7. Allman KC, Stevens MJ, Wieland DM, Hutchins GD, Wolfe ER Jr, Greene DA, Schwaiger M (1993) Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 22(5):1425–1432

    Article  CAS  PubMed  Google Scholar 

  8. Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M (2001) Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med 345(10):731–738. https://doi.org/10.1056/NEJMoa010519

    Article  CAS  PubMed  Google Scholar 

  9. Calkins H, Allman K, Bolling S, Kirsch M, Wieland D, Morady F, Schwaiger M (1993) Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation 88(1):172–179

    Article  CAS  PubMed  Google Scholar 

  10. Carrio I (2001) Cardiac neurotransmission imaging. J Nucl Med 42(7):1062–1076

    CAS  PubMed  Google Scholar 

  11. Pietila M, Malminiemi K, Ukkonen H, Saraste M, Nagren K, Lehikoinen P, Voipio-Pulkki LM (2001) Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med 28(3):373–376

    Article  CAS  PubMed  Google Scholar 

  12. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M (1998) Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 98(10):961–968

    Article  CAS  PubMed  Google Scholar 

  13. Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, Schober O (2006) Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT. J Nucl Med 47(10):1635–1642

    PubMed  Google Scholar 

  14. Hernandez FC, Sanchez M, Alvarez A, Diaz J, Pascual R, Perez M, Tovar I, Martinez P (2000) A five-year report on experience in the detection of pheochromocytoma. Clin Biochem 33(8):649–655

    Article  CAS  PubMed  Google Scholar 

  15. John H, Ziegler WH, Hauri D, Jaeger P (1999) Pheochromocytomas: can malignant potential be predicted? Urology 53(4):679–683

    Article  CAS  PubMed  Google Scholar 

  16. Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366(9486):665–675. https://doi.org/10.1016/S0140-6736(05)67139-5

    Article  PubMed  Google Scholar 

  17. Mann GN, Link JM, Pham P, Pickett CA, Byrd DR, Kinahan PE, Krohn KA, Mankoff DA (2006) [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Ann Surg Oncol 13(2):187–197. https://doi.org/10.1245/ASO.2006.04.022

    Article  PubMed  Google Scholar 

  18. Pacak K, Ilias I, Adams KT, Eisenhofer G (2005) Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med 257(1):60–68. https://doi.org/10.1111/j.1365-2796.2004.01425.x

    Article  CAS  PubMed  Google Scholar 

  19. Shulkin BL, Wieland DM, Baro ME, Ungar DR, Mitchell DS, Dole MG, Rawwas JB, Castle VP, Sisson JC, Hutchinson RJ (1996) PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 37(1):16–21

    CAS  PubMed  Google Scholar 

  20. Shulkin BL, Wieland DM, Schwaiger M, Thompson NW, Francis IR, Haka MS, Rosenspire KC, Shapiro B, Sisson JC, Kuhl DE (1992) PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 33(6):1125–1131

    CAS  PubMed  Google Scholar 

  21. Trampal C, Engler H, Juhlin C, Bergstrom M, Langstrom B (2004) Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology 230(2):423–428. https://doi.org/10.1148/radiol.2302021678

    Article  PubMed  Google Scholar 

  22. Yamamoto S, Hellman P, Wassberg C, Sundin A (2012) 11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma: a single center experience over 11 years. J Clin Endocrinol Metab 97(7):2423–2432. https://doi.org/10.1210/jc.2011-3342

    Article  CAS  PubMed  Google Scholar 

  23. Nagren K, Muller L, Halldin C, Swahn CG, Lehikoinen P (1995) Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate. Nucl Med Biol 22(2):235–239

    Article  CAS  PubMed  Google Scholar 

  24. Van Dort ME, Tluczek L (2000) Synthesis and carbon-11 labeling of the stereoisomers of meta-hydroxyephedrine (HED) and meta-hydroxypseudoephedrine (HPED). J Label CPD Radiopharm 43(6):603–612

    Article  Google Scholar 

  25. Jewett DM (1992) A simple synthesis of [11C]methyl triflate. Int J Rad Appl Instrum A 43(11):1383–1385

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the fund of National Key Clinical Specialty Project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qiusong Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, L., Li, X., Dong, L. et al. A novel strategy for the preparation of the injectable PET/CT radiopharmaceutical (-)-[11C]-(1R,2S)-meta-hydroxyephedrine ((-)-[11C]HED. J Radioanal Nucl Chem 320, 543–549 (2019). https://doi.org/10.1007/s10967-019-06534-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-019-06534-5

Keywords

Navigation